Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers

Objective: An increasing number of patients with advanced pancreatic or biliary tract cancer who progress after a gemcitabine-containing regimen are candidates for further chemotherapy. We therefore evaluated a fully oral regimen of capecitabine and celecoxib (CapCel) as second-line treatment in the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Oncology 2009-01, Vol.76 (4), p.254-261
Hauptverfasser:	Pino, Maria S., Milella, Michele, Gelibter, Alain, Sperduti, Isabella, De Marco, Salvatore, Nuzzo, Carmen, Bria, Emilio, Carpanese, Livio, Ruggeri, Enzo M., Carlini, Paolo, Cognetti, Francesco
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - mortality Adult Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Biliary Tract Neoplasms - drug therapy Biliary Tract Neoplasms - mortality Biological and medical sciences Capecitabine Carcinoma, Pancreatic Ductal - drug therapy Carcinoma, Pancreatic Ductal - mortality Celecoxib Chemotherapy Clinical outcomes Clinical Study Clinical trials Deoxycytidine - administration & dosage Deoxycytidine - adverse effects Deoxycytidine - analogs & derivatives Female Fluorouracil - administration & dosage Fluorouracil - adverse effects Fluorouracil - analogs & derivatives Gastroenterology. Liver. Pancreas. Abdomen Humans Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Middle Aged Oncology Pancreatic cancer Pancreatic Neoplasms - drug therapy Pancreatic Neoplasms - mortality Pharmacology Prospective Studies Pyrazoles - administration & dosage Pyrazoles - adverse effects Sulfonamides - administration & dosage Sulfonamides - adverse effects Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!